Contact Details
|
Merlin Nexus
Main Office
230 Park Avenue Suite 928
New York, New York
10169
Phone:
+1 (646) 227-5270
Fax:
+1 (646) 227-5201
See map: Google Maps |
Corporate Profile
Web Site:
Registration country:
United States
Company type:
Sample Investments
| Company | Profile | Amount | Industry | Ctry | Stage | Date | ||
|---|---|---|---|---|---|---|---|---|
| ARYx Therapeutics Inc | Pharmaceuticals | US | ||||||
| AVEO Pharmaceuticals Inc | A biopharmaceutical company discovering, developing and commercializing cancer therapeutics. | Pharmaceuticals | US | |||||
| Auxilium Pharmaceuticals Inc | Pharmaceuticals | US | ||||||
| Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | Pharmaceuticals | US | |||||
| Calypso Medical Technologies Inc | A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. | Medical Equipment | US | |||||
| Cougar Biotechnology Inc | Biotechnology | US | ||||||
| ILEX Oncology Inc | Pharmaceuticals | US | ||||||
| Nabi Biopharmaceuticals | Biotechnology | US | ||||||
| Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | Biotechnology | US | |||||
| Rigel Pharmaceuticals Inc | Biotechnology | US | ||||||
| Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | Biotechnology | US | Apr 2009 |
Current employees
| Name | Job title | Office | ||
|---|---|---|---|---|
| Bob Ai | NA | New York | ||
| Alberto Bianchinotti | Chief Financial Officer | New York | ||
| David Gould | NA | New York | ||
| Christian Richard | Head of Research | New York | ||
| Dominique Semon | Chief Investment Officer | New York |
RECORD ID: 3162
